What's new

EMEA-003501-PIP01-23

EMEA-003501-PIP01-23

Feb 19, 2025 - 18:29
 0
EMEA-003501-PIP01-23
EMEA-003501-PIP01-23
Read More

Tags:

Previous Article

Historic Milestone: The Global Hotel Development Pipeline Surpasses 15,800 Proje...

Next Article

AdventHealth leans into 'whole-person' cancer care

Related Posts

EMA workshop on the challenges in drug development, regulation and clinical practice for immunoglobulins, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 March 2025, 14:00 (CET) to 5 March 2025, 18:00 (CET)

EMA workshop on the challenges in drug development, reg...

Feb 19, 2025  0

EMEA-002762-PIP02-20-M02

EMEA-002762-PIP02-20-M02

Feb 14, 2025  0

Orphan designation: N-(2-Methoxyethyl)-6-methyl-N-[(3-methyl-2-thienyl)methyl]-2-oxo-1,2-dihydropyridine-4-carboxamide Treatment of glycogen storage disease type IV, 16/01/2025 Positive

Orphan designation: N-(2-Methoxyethyl)-6-methyl-N-[(3-m...

Feb 20, 2025  0